Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07513376 |
| Title | A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) (INTerpath-014) |
| Acronym | INTerpath-014 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NHO Revive Research Institute, LLC ( Site 3218) | RECRUITING | Lincoln | Nebraska | 68506 | United States | Details |
| Renown Regional Medical Center-Renown Health Medical Oncology ( Site 3207) | RECRUITING | Reno | Nevada | 89502 | United States | Details |
| Altru Health System ( Site 3254) | RECRUITING | Grand Forks | North Dakota | 58201 | United States | Details |
| One Clinical Research ( Site 0501) | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |
| Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2503) | RECRUITING | Kingston | Ontario | K7L 2V7 | Canada | Details |